| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09171d88ff4e3ae41b76a3ee30bcc184 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate |
2010-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_646f7774eb485346aab1ca1cbb56557d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34b6ffb5065880e2681c27aa2da26764
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a00ec725a08d7baedc5b9e6cf96396b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9cf40e96b1ec359193ac9668ffefe87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e6cf7cdb22987c867728efb1972cba9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_262a86e819b9a7338d9f512dd397c435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e58058087676e5753efdebb68f2772ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9071e97cd3e743849e687638716b9c85 |
| publicationDate |
2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2453314-C1 |
| titleOfInvention |
Combination possessing antiaggregant, lipid-regulating and gastroprotective activities, pharmaceutical composition |
| abstract |
FIELD: medicine. n SUBSTANCE: what is offered is a solid dosage pharmaceutical composition containing a combination of acetylsalicylic acid and ethylmethyl hydroxypyridine malate and ethylmethyl hydroxypyridine succinate possessing antiaggregant, lipid-regulating and gastroprotective activities. What is shown is substantial prolongation of shelf life of the solid dosage form. n EFFECT: pharmacological and pharmacokinetic findings of the new composition make perspective in manufacturing of the solid dosage drugs for preventing and treating obesity, pathological conditions of the cardiovascular system, preventing ischemic disorders with manifested atherosclerosis, old infarction, ischemic stroke; peripheral artery disease. n 10 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2686462-C1 |
| priorityDate |
2010-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |